Skip to content
← Back to this collection

PUBLICATIONS · 38898388

Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
BMC Cancer
Publication date
2024 Jun 19
First author
Tirtei E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tirtei E
      type
      Author
    2. name
      Campello A
      type
      Author
    3. name
      Sciannameo V
      type
      Author
    4. name
      Asaftei SD
      type
      Author
    5. name
      Meazza C
      type
      Author
    6. name
      Sironi G
      type
      Author
    7. name
      Longhi A
      type
      Author
    8. name
      Ibrahim T
      type
      Author
    9. name
      Tamburini A
      type
      Author
    10. name
      Coccoli L
      type
      Author
    11. name
      Crocco F
      type
      Author
    12. name
      Cagnazzo C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tirtei E
      type
      Author
    2. name
      Campello A
      type
      Author
    3. name
      Sciannameo V
      type
      Author
    4. name
      Asaftei SD
      type
      Author
    5. name
      Meazza C
      type
      Author
    6. name
      Sironi G
      type
      Author
    7. name
      Longhi A
      type
      Author
    8. name
      Ibrahim T
      type
      Author
    9. name
      Tamburini A
      type
      Author
    10. name
      Coccoli L
      type
      Author
    11. name
      Crocco F
      type
      Author
    12. name
      Cagnazzo C
      type
      Author
    bibliography ids
    1. nci-bib-f3df2830a2d8a0df920eff9e
    book metadata
    content sha256
    3d9f8dbdca81a93bb16be80d04355db73f0eff6cc1ed0f1ef25f53f9b060792e
    document type
    citation
    dois
    1. 10.1186/s12885-024-12498-x
    electronic publication date
    display
    2024 Jun 19
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38898388
    immutable id
    pubmed:38898388@3d9f8dbdca81a93bb16be80d04355db73f0eff6cc1ed0f1ef25f53f9b060792e
    journal
    abbreviation
    BMC Cancer
    issn electronic
    1471-2407
    issn print
    Source null
    issue
    1
    name
    BMC cancer
    nlm unique id
    100967800
    pages
    747
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38898388
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      fd3877e9ec3705dedc211cf2371458f20344403163e186c02fcd2857b2abbe9a
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2024 Jun 19
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38898388/
      title
      Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study.

      Preserved source evidence · Not medical advice